dc.contributor.author |
Otero Vegas, Larissa |
|
dc.contributor.author |
De Orbegoso, A. |
|
dc.contributor.author |
Navarro, A. F. |
|
dc.contributor.author |
Ríos, J. |
|
dc.contributor.author |
Párraga, T. |
|
dc.contributor.author |
Gotuzzo Herencia, José Eduardo |
|
dc.contributor.author |
Seas Ramos, Carlos Rafael |
|
dc.contributor.author |
Van der Stuyft, P. |
|
dc.date.accessioned |
2019-02-06T14:57:42Z |
|
dc.date.available |
2019-02-06T14:57:42Z |
|
dc.date.issued |
2015 |
|
dc.identifier.uri |
https://hdl.handle.net/20.500.12866/5499 |
|
dc.description.abstract |
OBJECTIVE: To determine the time from diagnosis to start of multidrug resistant tuberculosis (MDR TB) treatment in Lima, Peru. METHODS: We studied new smear-positive TB adults that were started on MDR TB treatment or that were switched to it between June 2008 and December 2011. RESULTS: Time from the first positive smear to MDR-TB treatment was >30 days in 35% (13/37) of patients. Among the 27% (24/88) of patients that switched to MDR-TB treatment, time from the last dose of a drug-susceptible regimen was >30 days. CONCLUSION: Start of and switching to MDR TB treatment is still delayed. |
en_US |
dc.language.iso |
eng |
|
dc.publisher |
Wiley |
|
dc.relation.ispartofseries |
Tropical Medicine and International Health |
|
dc.rights |
info:eu-repo/semantics/restrictedAccess |
|
dc.rights.uri |
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es |
|
dc.subject |
Peru |
en_US |
dc.subject |
Adult |
en_US |
dc.subject |
Female |
en_US |
dc.subject |
Humans |
en_US |
dc.subject |
Male |
en_US |
dc.subject |
Retrospective Studies |
en_US |
dc.subject |
Tuberculosis |
en_US |
dc.subject |
Time Factors |
en_US |
dc.subject |
Peru/epidemiology |
en_US |
dc.subject |
tuberculosis |
en_US |
dc.subject |
tuberculose |
en_US |
dc.subject |
Outcome Assessment (Health Care) |
en_US |
dc.subject |
Incidence |
en_US |
dc.subject |
Antitubercular Agents/therapeutic use |
en_US |
dc.subject |
Drug Substitution/statistics & numerical data |
en_US |
dc.subject |
multidrug resistant |
en_US |
dc.subject |
multiresistante |
en_US |
dc.subject |
multirresistente |
en_US |
dc.subject |
Perou |
en_US |
dc.subject |
temps jusqu'au traitement |
en_US |
dc.subject |
Tiempo hasta el inicio del tratamiento |
en_US |
dc.subject |
time to treatment |
en_US |
dc.subject |
Tuberculosis, Multidrug-Resistant/drug therapy/epidemiology |
en_US |
dc.subject |
Tuberculosis, Pulmonary/drug therapy/epidemiology |
en_US |
dc.title |
Time to initiation of multidrug-resistant tuberculosis treatment and its relation with outcome in a high incidence district in Lima, Peru |
en_US |
dc.type |
info:eu-repo/semantics/article |
|
dc.identifier.doi |
https://doi.org/10.1111/tmi.12430 |
|
dc.subject.ocde |
https://purl.org/pe-repo/ocde/ford#3.03.06 |
|
dc.relation.issn |
1365-3156 |
|